PortfoliosLab logoPortfoliosLab logo
NG.L vs. AZN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NG.L vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in National Grid plc (NG.L) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

NG.L is traded in GBp, while AZN is traded in USD. To make them comparable, the AZN values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, NG.L achieves a 8.08% return, which is significantly higher than AZN's 1.79% return. Over the past 10 years, NG.L has underperformed AZN with an annualized return of 7.83%, while AZN has yielded a comparatively higher 16.63% annualized return.


NG.L

1D
-1.23%
1M
-3.43%
YTD
8.08%
6M
8.65%
1Y
20.62%
3Y*
12.91%
5Y*
12.54%
10Y*
7.83%

AZN

1D
-2.40%
1M
1.44%
YTD
1.79%
6M
1.36%
1Y
29.80%
3Y*
7.39%
5Y*
13.34%
10Y*
16.63%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NG.L vs. AZN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NG.L
National Grid plc
8.08%25.50%3.80%11.91%-2.57%27.27%-4.19%30.69%-9.07%-3.65%
AZN
AstraZeneca PLC
1.79%33.09%1.12%-3.63%33.30%20.79%0.09%30.52%20.61%21.59%

Correlation

The correlation between NG.L and AZN is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.24

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.22

Correlation (10Y)
Calculated over the trailing 10-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Jul 5, 2007

0.28

Fundamentals

Market Cap

NG.L:

£59.84B

AZN:

$283.40B

EPS

NG.L:

£1.24

AZN:

$6.66

PE Ratio

NG.L:

9.72

AZN:

27.27

PEG Ratio

NG.L:

0.23

AZN:

0.04

PS Ratio

NG.L:

1.65

AZN:

4.69

PB Ratio

NG.L:

1.52

AZN:

5.99

Total Revenue (TTM)

NG.L:

£36.07B

AZN:

$60.44B

Gross Profit (TTM)

NG.L:

£29.59B

AZN:

$49.37B

EBITDA (TTM)

NG.L:

£14.89B

AZN:

$20.47B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NG.L vs. AZN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NG.L
NG.L Risk / Return Rank: 6969
Overall Rank
NG.L Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
NG.L Sortino Ratio Rank: 6565
Sortino Ratio Rank
NG.L Omega Ratio Rank: 6868
Omega Ratio Rank
NG.L Calmar Ratio Rank: 6868
Calmar Ratio Rank
NG.L Martin Ratio Rank: 7373
Martin Ratio Rank

AZN
AZN Risk / Return Rank: 7373
Overall Rank
AZN Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
AZN Sortino Ratio Rank: 7373
Sortino Ratio Rank
AZN Omega Ratio Rank: 6969
Omega Ratio Rank
AZN Calmar Ratio Rank: 7474
Calmar Ratio Rank
AZN Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NG.L vs. AZN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for National Grid plc (NG.L) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NG.LAZNDifference
Sharpe ratioReturn per unit of total volatility

-0.18

Sortino ratioReturn per unit of downside risk

-0.62

Omega ratioGain probability vs. loss probability

1.20

1.23

-0.03

Calmar ratioReturn relative to maximum drawdown

1.36

2.00

-0.64

Martin ratioReturn relative to average drawdown

4.16

5.24

-1.09

NG.L vs. AZN - Sharpe Ratio Comparison

The current NG.L Sharpe Ratio is 1.04, which is comparable to the AZN Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of NG.L and AZN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NG.LAZNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.04

1.21

-0.18

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.65

0.58

+0.07

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.38

0.67

-0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

0.49

0.54

-0.05

Drawdowns

NG.L vs. AZN - Drawdown Comparison

The maximum NG.L drawdown since its inception was -37.82%, which is greater than AZN's maximum drawdown of -32.75%. Use the drawdown chart below to compare losses from any high point for NG.L and AZN.


Loading charts...

Drawdown Indicators


NG.LAZNDifference

Max Drawdown

Largest peak-to-trough decline

-37.82%

-32.75%

-5.07%

Max Drawdown (1Y)

Largest decline over 1 year

-15.14%

-15.03%

-0.11%

Max Drawdown (3Y)

Largest decline over 3 years

-20.16%

-25.73%

+5.57%

Max Drawdown (5Y)

Largest decline over 5 years

-29.57%

-25.73%

-3.84%

Max Drawdown (10Y)

Largest decline over 10 years

-30.48%

-28.56%

-1.92%

Current Drawdown

Current decline from peak

-11.88%

-12.00%

+0.12%

Average Drawdown

Average peak-to-trough decline

-9.19%

-8.23%

-0.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.95%

5.71%

-0.76%

Volatility

NG.L vs. AZN - Volatility Comparison

National Grid plc (NG.L) has a higher volatility of 10.52% compared to AstraZeneca PLC (AZN) at 7.38%. This indicates that NG.L's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NG.LAZNDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.52%

7.38%

+3.14%

Volatility (6M)

Calculated over the trailing 6-month period

17.15%

17.33%

-0.18%

Volatility (1Y)

Calculated over the trailing 1-year period

19.83%

24.85%

-5.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.40%

23.13%

-3.73%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.41%

24.90%

-4.49%

Dividends

NG.L vs. AZN - Dividend Comparison

NG.L's dividend yield for the trailing twelve months is around 4.03%, more than AZN's 2.93% yield.


PositionTTM20252024202320222021202020192018201720162015
AZN
AstraZeneca PLC
2.93%1.70%2.27%2.15%2.12%2.35%2.80%2.81%3.69%3.95%5.01%4.06%
NG.L
National Grid plc
4.03%4.14%5.79%5.39%3.85%3.47%4.89%4.91%4.53%15.43%4.97%5.01%

Financials

NG.L vs. AZN - Financials Comparison

This section allows you to compare key financial metrics between National Grid plc and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


6.00B8.00B10.00B12.00B14.00B16.00B20222023202420252026
10.62B
15.29B
(NG.L) Total Revenue
(AZN) Total Revenue
Please note, different currencies. NG.L values in GBp, AZN values in USD

NG.L vs. AZN - Profitability Comparison

The chart below illustrates the profitability comparison between National Grid plc and AstraZeneca PLC over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%100.0%20222023202420252026
39.0%
82.5%
Portfolio components
NG.L - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, National Grid plc reported a gross profit of 4.15B and revenue of 10.62B. Therefore, the gross margin over that period was 39.0%.

AZN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.

NG.L - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, National Grid plc reported an operating income of 4.15B and revenue of 10.62B, resulting in an operating margin of 39.0%.

AZN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.

NG.L - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, National Grid plc reported a net income of 2.62B and revenue of 10.62B, resulting in a net margin of 24.7%.

AZN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.


Frequently Asked Questions


NG.L and AZN have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NG.L and AZN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer